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Introduction
Sly syndrome or mucopolysaccharidosis type VII (MPS VII) (OMIM 
253220) is a rare genetic disorder inherited in an autosomal recessive 
mode. The condition was first described by Sly et al. (1). The GUSB gene 
mutation results in β-glucuronidase enzyme deficiency and consequently, 
accumulation of glycosaminoglycans (GAGs) in lysosomes (2).The 
accumulation of heparin sulfate, dermatan sulfate, chondroitin-4 
sulfate, and chondroitin-6 sulfate causes various manifestations in 
different organs (3). The patients express a wide range of phenotypic 
heterogeneity, probably due to overexpression or multiallelic mutations 
(4). The most commonly observed characteristic is nonimmune hydrops 
fetalis at birth or prenatal period. Other main features of this disorder are 
corneal clouding, heavy eyebrows, coarse facies, dysostosis multiplex, 
macroglossia, respiratory infection, sensorineural hearing loss, kyphosis, 
and hepatosplenomegaly (5). Nonimmune hydrops fetalis is a prominent 
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Abstract
Objectives
Mucopolysaccharidosis type VII (MPS VII) or Sly syndrome is a rare 
autosomal recessive disorder caused by deficiency of β-glucuronidase 
enzyme, which is involved in degradation of glycosaminoglycans. 
The lack of β-glucuronidase in this lysosomal storage disorder is 
characterized by various manifestations such as nonimmune hydrops 
fetalis, spinal deformity, organomegaly, dysostosis multiplex, 
intellectual disability, and eye involvement. It is caused by a mutation 
in GUSB gene located on chromosome 7 q11. The current study 
reported an Iranian female with MPS VII and a novel mutation (c. 
542G>T, p.Arg181Leu) in GUSB gene.
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symptom before birth.
In conclusion, lysosomal storage disease, 
especially MPS VII, should be considered in the 
case of nonimmune hydrops fetalis.
The current study reported an Iranian female 
presented with non-progressive nonimmune 
hydrops fetalis and a novel mutation (c. 542G>T, 
p.Arg181Leu) in GUSB gene.
Case Report
A 28-month-old female patient was referred 
to Endocrine Clinic due to kyphosis and 
hepatosplenomegaly. She was the first child of 
healthy consanguineous Iranian parents without 
any diseases and a history of abortion in her mother, 
but a history of two stillbirths was reported in her 
uncle’s family due to hydrops fetalis. The patient 
had received intrauterine transfusion of packed 
cell at 23rd and 28th week of gestation due to 
hydrops fetalis. She was delivered spontaneously 
at 37th week of gestation. There was no symptom 
of hydrops fetalis or ascites at birth. She was 
hospitalized three times due to pneumonia. 
 On physical examination, she had short stature 
with a coarse facies, thoracolumbar kyphosis, 
and scoliosis; hepatosplenomegaly and umbilical 
hernia were also present. Developmental and 
neurologic examinations revealed significant 
delay of fine motor skills and speech. She had no 
seizure and head circumference was normal. X-ray 
examination showed signs of dysostosis multiplex, 
scoliosis, kyphosis, and vertebral beaking.
According to these findings, urine was tested 
for GAGs and the result was positive. Venous 
blood sample was also collected and used for 
DNA extraction and whole exome sequencing 
was carried out using Ion Torrent platform (Life 
Technologies Corporation, Carlsbad, CA). Library 
and template preparation followed by high 
throughput sequencing were performed based 
on the manufacturers’ guidelines. Variants were 
called, filtered, and analyzed using the Ion Reporter 
pipeline (Life Technologies Corporation ,USA), 
focusing on genes involved in hydrops fetalis. The 
candidate variant was confirmed through Sanger 
sequencing along with co-segregation analysis. 
Whole exome sequencing revealed a DNA variant 
(c.542G>T, p.Arg181Leu, NM_001284290.1) 
in GUSB gene, in the affected individual. DNA 
variants are shown in Table 1.
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The result of further molecular genetic studies of 
the other family members are shown below:
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Discussion
Sly syndrome or MPS VII is a potential lethal 
disease caused by mutations in the GUSB gene 
(6). These mutations cause glucuronidase enzymes 
deficiency and GAG accumulation in lysosomes. 
The exact incidence of this disease is not known, 
but it is estimated to be 1: 300,000 to 1: 2,000,000 
(7). A number of patients may not be diagnosed 
due to prenatal deaths (5). 
Patients with MPS VII show a wide range of 
symptoms in terms of the phenotype. The most 
prominent symptom before birth is the presence 
of nonimmune hydrops fetalis. Up to 15% of the 
causes of hydrops fetalis are due to lysosomal 
storage diseases (8). 
In some studies, it is reported that the presence 
of hydrops fetalis is associated with severe fetal 
disease and postnatal death (9). However, in the 
study by Montanto et al., performed on 56 patients 
with Sly syndrome, 13 patients with a history of 
nonimmune hydrops fetalis in embryonic period 
showed a wide range of symptoms after birth; 
therefore, it seems that the presence of hydrops 
fetalis is not a reliable predictive factor to determine 
the severity of the disease (5). The current study 
patient, despite the presence of hydrops fetalis 
and receiving two intrauterine packed cells during 
pregnancy, survived for 2.5 years. A wide range 
of heterogeneity phenotypes is observed in the 
MPS VII (2,5,8). The mutation in the GUSB gene 
affects the structure, function, and stability of the 
GUSB gene and the glucuronidase enzyme (6). The 
accumulation of GAGs in lysosomes increases the 
size of lysosomes, and as a result causes oversized 
organs. On the other hand, GAGs interact with 
the function of other proteins in lysosomes and 
affect other cell functions (7). It seems that the 
involvement of some organs in the disease is due 
to these interactions.   
Monatano et al., examined the clinical symptoms 
in 56 patients with MPS VII. In their study, the 
most common symptom was coarse facial features, 
observed in 87% of patients. Other progressive 
symptoms included corneal clouding, enlarged 
tongue, heart abnormalities, organomegaly, 
neurodevelopmental delay, and skeletal deformity 
(5). The current study patient showed these signs 
on admission with a slow progression over two 
years of follow-up.
The presentation of the under study patient was a 
nonimmune hydrops fetalis. According to the study 
by Montano, approximately 40% of patients with 
nonimmune hydrops fetalis show a wide range of 
outcomes. The hydrops fetalis may be caused by 
hepatic sinusoidal infiltration and obstruction that 
result in a generalized edema (5). Cardiovascular 
involvement may also play a role in the development 
of the edema (10). Therefore, lysosomal storage 
disease, especially MPS VII, should be considered 
in the presence of nonimmune hydrops fetalis.
Determination of the level of urinary GAG helps to 
evaluate patients suspected of Sly syndrome (11). 
In some studies, a low level of GAG secretion 
in urine was associated with longer survival (8), 
but some other studies stated that urinary GAG 
level was not an appropriate and reliable indicator 
to predict the severity of the disease (7). This 
difference seems to be due to the method used to 
study the urine GAG. In the current study patient, 
the result of the GAG quality assay was positive, 
but the quantity assessment was not performed. 
The genotype-phenotype correlation studies are 
difficult due to the rare nature of this disease 
(7). Conzelmann et al., described the theory of 
residual enzyme activity to explain the differences 
in severity of the disease (12). Based on their 
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theory, various mutations in the GUSB gene cause 
different degrees of reduced activity or deficiency 
of the enzyme and this difference leads to different 
clinical symptoms and variations in severity of the 
disease (12).
In the current study patient, a genetic study was 
conducted indicating a novel mutation in the GUSB 
gene. This variant (c.542G>T, p.Arg181Leu, 
NM_001284290.1) was not previously reported; 
therefore, Sanger sequencing was performed 
and the parents of the patient, as well as two 
other members of the family, were examined for 
this variant. The obtained results indicated that 
the family members were heterozygotes for this 
variant. The variant was classified as a “variant 
of unknown clinical significance (VUS) based on 
the American College of Medical Genetics and 
Genomics guidelines. There is a need to study the 
enzyme in order to prove a new mutation. However, 
since the result of the enzyme assessment was not 
available, this variant was classified as a VUS.
In Conclusion 
lysosomal storage disease, especially MPS VII, 
should be considered in the case of nonimmune 
hydrops fetalis.
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